Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK.
J Mol Biol. 2020 Jan 3;432(1):3-27. doi: 10.1016/j.jmb.2019.05.010. Epub 2019 May 11.
Autophagy, self-eating, is a pivotal catabolic mechanism that ensures homeostasis and survival of the cell in the face of stressors as different as starvation, infection, or protein misfolding. The importance of the research in this field was recognized by the general public after the Nobel Prize for Physiology or Medicine was awarded in 2016 to Yoshinori Ohsumi for discoveries of the mechanisms of autophagy using yeast as a model organism. One of the seminal findings of Ohsumi was on the role ubiquitin-like proteins (UBLs)-Atg5, Atg12, and Atg8-play in the formation of the double-membrane vesicle autophagosome, which is the functional unit of autophagy. Subsequent work by several groups demonstrated that, like the founding member of the UBL family ubiquitin, these small but versatile protein and lipid modifiers interact with a plethora of proteins, which either directly regulate autophagosome formation, for example, components of the Atg1/ULK1 complex, or are involved in cargo recognition, for example, Atg19 and p62/SQSTM1. By tethering the cargo to the UBLs present on the forming autophagosome, the latter proteins were proposed to effectively act as selective autophagy receptors. The discovery of the selective autophagy receptors brought a breakthrough in the autophagy field, supplying the mechanistic underpinning for the formation of an autophagosome selectively around the cytosolic cargo, that is, a protein aggregate, a mitochondrion, or a cytosolic bacterium. In this historical overview, I highlight key steps that the research into selective autophagy has been taking over the past 20 years. I comment on their significance and discuss current challenges in developing more detailed knowledge of the mechanisms of selective autophagy. I will conclude by introducing the new directions that this dynamic research field is taking into its third decade.
自噬,即自我吞噬,是一种关键的分解代谢机制,可确保细胞在面临不同应激源(如饥饿、感染或蛋白质错误折叠)时的内稳态和存活。这个领域的研究重要性在 2016 年因生理学或医学诺贝尔奖授予 Yoshinori Ohsumi 而被公众所认识,他使用酵母作为模式生物发现了自噬的机制。Ohsumi 的一项重要发现是泛素样蛋白(UBLs)-Atg5、Atg12 和 Atg8 在双层膜囊泡自噬体形成中的作用,自噬体是自噬的功能单位。随后,几个研究小组的工作表明,像 UBL 家族的创始成员泛素一样,这些小而多功能的蛋白质和脂质修饰物与大量蛋白质相互作用,这些蛋白质或直接调节自噬体的形成,例如 Atg1/ULK1 复合物的组成部分,或参与货物识别,例如 Atg19 和 p62/SQSTM1。通过将货物与形成的自噬体上的 UBL 连接,这些蛋白质被认为有效地作为选择性自噬受体发挥作用。选择性自噬受体的发现为自噬领域带来了突破,为自噬体在胞质货物(即蛋白质聚集体、线粒体或胞质细菌)周围选择性形成提供了机制基础。在这篇历史综述中,我强调了过去 20 年来选择性自噬研究的关键步骤。我评论了它们的意义,并讨论了当前在发展对选择性自噬机制的更详细了解方面的挑战。最后,我将介绍这个充满活力的研究领域在进入第三个十年时所采取的新方向。